Catalyst Wire Dossier Catalyst Wire Dossier

Jubereq

denosumab · Accord Healthcare S.L.U.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Jubereq, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: EMA Authorised: Jubereq (denosumab) — Accord Healthcare S.L.U.

See pricing